Kwick Forensic Solutions IPO Day 1: GMP ₹63 (+₹2)

Welcome back to our daily IPO updates! Today, we’re diving into the first day of the Kwick Forensic Solutions SME IPO on the BSE. As expected for many SME IPOs, Day 1 is often about building momentum. Let’s see how Kwick Forensic Solutions is shaping up.

Subscription Status

At the close of Day 1, Kwick Forensic Solutions’ IPO is showing 0x subscription across all categories: Retail, Non-Institutional Investors (NII), and Qualified Institutional Buyers (QIB). This isn’t unusual for the opening day of an SME issue. Investors often take their time to analyze the opportunity, especially in the SME segment where due diligence might be more hands-on. The absence of initial subscription numbers doesn’t necessarily signal a lack of interest; rather, it suggests that the bulk of the subscriptions will likely come in during the latter half of the IPO period, which runs from August 27th to August 31st, 2026. We’ll be watching closely to see if this trend shifts in the coming days.

GMP Update

Interestingly, the Grey Market Premium (GMP) for Kwick Forensic Solutions has seen a positive uptick. Yesterday, the GMP stood at ₹61, and today it’s climbed to ₹63, marking an increase of ₹2. This is encouraging news for potential investors. A rising GMP generally reflects growing demand and positive market sentiment towards the IPO. Based on the issue price of ₹90 and the current GMP of ₹63, the expected listing price is around ₹153 (₹90 + ₹63). This suggests a potential listing gain of approximately 70%, which is quite attractive.

Should You Apply?

So, the million-dollar question: should you be applying for Kwick Forensic Solutions? Let’s break it down. On one hand, the zero subscription on Day 1 is typical for SME IPOs and shouldn’t be a cause for immediate alarm. Many investors prefer to wait until the last few days to subscribe, especially if they’re looking at the potential listing gains indicated by the GMP. The GMP itself is showing a healthy upward trend, pointing towards strong investor appetite and a potentially robust listing. The expected listing price of ₹153 offers a significant upside from the issue price of ₹90.

However, it’s crucial to remember that GMP is an unofficial indicator and not a guarantee of listing performance. SME IPOs, by their nature, carry higher risks compared to mainboard listings. Thorough research into the company’s fundamentals, its business model, and the competitive landscape is paramount. As SEBI advisors often emphasize, investors should always invest within their risk appetite and after conducting their own due diligence. The lot size is 1600 shares, meaning an investment of ₹144,000 (1600 shares * ₹90 issue price) per lot. The potential gains are substantial, but so are the risks. Keep an eye on the subscription numbers as they roll in over the next few days.

View Full Kwick Forensic Solutions IPO Details